iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology
April 28, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 28, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11
April 27, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems
April 26, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 26, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced significant...
iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions
April 21, 2022 08:00 ET
|
iCAD, Inc.
Company expects preliminary estimated revenue to be $7.5 million Timothy Norris Irish appointed Chairman of the Board of Directors, successor CFO search underway NASHUA, N.H., April 21, 2022 ...
iCAD Launches ProFound Insights, ProFound Impact Webinar Series on April 27
April 19, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 19, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment
April 05, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 05, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
iCAD Highlights Breast Health AI Platform at the 2022 Healthcare Information and Management Systems Society (HIMSS) Meeting
March 14, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., March 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be...
iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference
March 10, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., March 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be...
iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference
March 09, 2022 11:21 ET
|
iCAD, Inc.
NASHUA, N.H., March 09, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD Among the First to Validate its AI Cancer Detection Solutions with the NVIDIA AI Enterprise Software Suite
March 02, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., March 02, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it is...